Persistent infection with high-risk human papillomavirus, particularly HPV16, is a major cause of cervical cancer and orogenital malignancies. Therapeutic DNA vaccines targeting viral oncoproteins represent a promising strategy to induce antitumor immune responses. However, the impact of antigen combinations in bicistr...
Ingrid Andrêssa de Moura, Karina Mayumi Tani Bezerra de Melo, L. R. S. Leal et al.· Molecules· 0 citations
Breast cancer is a major public health concern and the leading cause of cancer-related death among women. The controversial role of Human Papillomavirus (HPV) infection in breast cancer remains not fully elucidated, but accumulating evidence points toward the confirmation of genetic and epigenetic alterations induced b...
Vanessa Emanuelle Pereira Santos, Ingrid Andrêssa de Moura, Beatriz Eda de Oliveira Isídio et al.· Cellular Signalling· 0 citations
The high expression of E5—associated with immune evasion—combined with reduced mTOR expression suggests that HPV16 status may influence therapeutic response in breast cancer patients, reinforcing the importance of further studies investigating HPV activity in breast tumors to better understand its biological and clinic...
Beatriz Eda de Oliveira Isídio, Pedro Henrique Bezerra Fontes, Gabriel Rômulo Parente da Silva et al.· Exploration of Targeted Anti...· 1 citation
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.